HCV NS4B inhibitors (Gilead Sciences)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHCV NS4B inhibitors (Gilead Sciences)
Drug Alias NameHCV NS4B inhibitors (Pharmasset)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 4B inhibitors
TargetsNonstructural protein 4B
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A